Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Cardiol. Jun 26, 2024; 16(6): 329-338
Published online Jun 26, 2024. doi: 10.4330/wjc.v16.i6.329

Full Size Figure Download Figure

Figure 1 Flow diagram of the inclusion of study subjects. ACS: Acute coronary syndrome; CAG: Coronary angiography.

Citation: Saeki Y, Sawaguchi J, Akita S, Takamura TA, Fujibayashi K, Wakasa M, Akao H, Kitayama M, Kawai Y, Kajinami K. Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome. World J Cardiol 2024; 16(6): 329-338
URL: https://www.wjgnet.com/1949-8462/full/v16/i6/329.htm
DOI: https://dx.doi.org/10.4330/wjc.v16.i6.329

Saeki Y, Sawaguchi J, Akita S, Takamura TA, Fujibayashi K, Wakasa M, Akao H, Kitayama M, Kawai Y, Kajinami K. Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome. World J Cardiol 2024; 16(6): 329-338 [PMID: 38993583 DOI: 10.4330/wjc.v16.i6.329]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.